Evidence map›Paper›PMID 31349985›Full record

ArticleBiophysical journal2019

Interaction Between the a3 Region of Factor VIII and the TIL'E' Domains of the von Willebrand Factor.

Lisbeth Dagil, Kathrin S Troelsen, Gert Bolt, Lars Thim, Bo Wu, Xin Zhao, Edward G D Tuddenham, Thomas E Nielsen, David A Tanner, Johan H Faber and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Biophysical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Von Willebrand factor and hematogenous cancer metastasis under flow.Frontiers in cell and developmental biology · 2024
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Lisbeth DagilInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, London, United Kingdom; Novo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark.
Kathrin S TroelsenDepartment of Chemistry, Technical University of Denmark, Kongens Lyngby, Denmark.
Gert BoltNovo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark.
Lars ThimNovo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark.
Bo WuNovo Nordisk Research Center China, Beijing, China.
Xin ZhaoNovo Nordisk Research Center China, Beijing, China.
Edward G D TuddenhamInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, London, United Kingdom; Katharine Dormandy, Haemophilia Centre and Thrombosis Unit, Royal Free Hospital NHS Trust, London, United Kingdom.
Thomas E NielsenNovo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark.
David A TannerDepartment of Chemistry, Technical University of Denmark, Kongens Lyngby, Denmark.
Johan H FaberNovo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark.
Jens BreinholtNovo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark.
Jakob E RasmussenNovo Nordisk A/S, Novo Nordisk Park, Måløv, Denmark. Electronic address: jaor@novonordisk.com.
D Flemming HansenInstitute of Structural and Molecular Biology, Division of Biosciences, University College London, London, United Kingdom. Electronic address: d.hansen@ucl.ac.uk.
Novo Nordisk (Denmark) · DKInstitute of Structural and Molecular Biology · GBTechnical University of Denmark · DKUniversity College London · GB

Funding

Cancer Research UK FC001029Medical Research Council FC001029Medical Research Council MC_U117533887Wellcome TrustWellcome Trust 101569/Z/13/ZWellcome Trust FC001029
6 · The paper itself

Abstract

The von Willebrand factor (VWF) and coagulation factor VIII (FVIII) are intricately involved in hemostasis. A tight, noncovalent complex between VWF and FVIII prolongs the half-life of FVIII in plasma, and failure to form this complex leads to rapid clearance of FVIII and bleeding diatheses such as hemophilia A and von Willebrand disease (VWD) type 2N. High-resolution insight into the complex between VWF and FVIII has so far been strikingly lacking. This is particularly the case for the flexible a3 region of FVIII, which is imperative for high-affinity binding. Here, a structural and biophysical characterization of the interaction between VWF and FVIII is presented with focus on two of the domains that have been proven pivotal for mediating the interaction, namely the a3 region of FVIII and the TIL'E' domains of VWF. Binding between the FVIII a3 region and VWF TIL'E' was here observed using NMR spectroscopy, where chemical shift changes were localized to two β-sheet regions on the edge of TIL'E' upon FVIII a3 region binding. Isothermal titration calorimetry and NMR spectroscopy were used to characterize the interaction between FVIII and TIL'E' as well as mutants of TIL'E', which further highlights the importance of the β-sheet region of TIL'E' for high-affinity binding. Overall, the results presented provide new insight into the role the FVIII a3 region plays for complex formation between VWF and FVIII and the β-sheet region of TIL'E' is shown to be important for FVIII binding. Thus, the results pave the way for further high-resolution insights into this imperative complex.

Indexed as

CalorimetryFactor VIIIMagnetic Resonance SpectroscopyMutant ProteinsMutationProtein BindingProtein Domainsvon Willebrand FactorFactor VIIIMutant Proteinsvon Willebrand Factor

Identifiers

PMID31349985
PMCPMC6697466
OpenAlexW2956680313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.